Abstract |
We report our early experience in the use of intravenous Streptokinase in acute coronary occlusion in a peripheral hospital. From 1st November 1988 to 20th July 1989, 30 patients were treated with Streptokinase. The hospital mortality was 1/30 (3.3%) from a non- streptokinase related event. The commonest complication following streptokinase infusion was transient hypotension, affecting 10/30 patients. From a total of 30 patients, 3 had transient bleeding complications and was self limiting. Follow up coronary angiograms were performed on 17/30 patients, demonstrating a patent infarct related artery in 12/17 patients (70.6%). We concluded that it is both feasible and safe to use intravenous streptokinase in a peripheral setting in the treatment of acute myocardial infarction.
|
Authors | G Chia, N S Chan, P K Mah, L S Chew, A T Tan |
Journal | Annals of the Academy of Medicine, Singapore
(Ann Acad Med Singap)
Vol. 19
Issue 1
Pg. 27-9
(Jan 1990)
ISSN: 0304-4602 [Print] Singapore |
PMID | 2327718
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Female
- Follow-Up Studies
- Heart Failure
(therapy)
- Hospitals, Satellite
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Myocardial Infarction
(mortality, therapy)
- Shock, Cardiogenic
(therapy)
- Singapore
(epidemiology)
- Streptokinase
(administration & dosage)
- Survival Rate
|